Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 71335-2835

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 71335-2835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352835)

This is a description of a medication containing metoprolol succinate and metoprolol tartrate in tablet form. The tablets are film-coated and each tablet contains 47.5 mg of metoprolol succinate, equivalent to 50 mg of metoprolol tartrate. The usual dosage information can be found in the package insert through a QR code. The warning advises to keep the medication out of reach of children. The tablets should be stored at 25°C with excursions permitted to 15° to 30°C. The manufacturer of the medication is mentioned as Bryant Ranch Prepack, Inc. and it is manufactured by Alkem Laboratories Ltd.*

FDA Label Image

Metoprolol-structure (Metoprolol Structure)

FDA Label Image

Metoprolol-table1a (Metoprolol Table1a)

This description provides results for subgroups in the MERIT-HF clinical trial, focusing on total mortality and hospitalization for heart failure. The data compares Metoprolol Succinate Extended-Release tablets with Placebo, considering factors such as NYHA Class, ejection fraction, ischemic or non-ischemic etiology, sex, race, medical history, and heart rate. The table includes relative risk and confidence intervals for the United States cohort.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.